|
GPR180 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.110400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.558100E-02 |
| Normal-vs-Stage2 |
5.470200E-02 |
| Normal-vs-Stage3 |
1.205780E-01 |
| Normal-vs-Stage4 |
1.280190E-01 |
| Stage1-vs-Stage2 |
3.384600E-01 |
| Stage1-vs-Stage3 |
8.461200E-01 |
| Stage1-vs-Stage4 |
9.855400E-01 |
| Stage2-vs-Stage3 |
4.642800E-01 |
| Stage2-vs-Stage4 |
3.696800E-01 |
| Stage3-vs-Stage4 |
8.560000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.165900E-02 |
| Normal-vs-AfricanAmerican |
8.588800E-01 |
| Normal-vs-Asian |
2.684500E-02 |
| Caucasian-vs-AfricanAmerican |
1.177850E-01 |
| Caucasian-vs-Asian |
1.403790E-01 |
| AfricanAmerican-vs-Asian |
1.636380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.727960E-01 |
| Normal-vs-Female |
1.055950E-02 |
| Male-vs-Female |
7.234300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.591800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.249600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.516500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.299800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.782600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.866600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.060800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.592400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.008800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.147600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.431600E-01 |
| Normal-vs-Grade 2 |
2.060400E-02 |
| Normal-vs-Grade 3 |
1.331020E-01 |
| Normal-vs-Grade 4 |
1.863360E-01 |
| Grade 1-vs-Grade 2 |
9.993800E-01 |
| Grade 1-vs-Grade 3 |
5.983000E-01 |
| Grade 1-vs-Grade 4 |
6.766000E-01 |
| Grade 2-vs-Grade 3 |
1.973630E-01 |
| Grade 2-vs-Grade 4 |
3.964200E-01 |
| Grade 3-vs-Grade 4 |
8.889800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.357980E-02 |
| Normal-vs-ccB subtype |
3.514200E-02 |
| ccA subtype-vs-ccB subtype |
7.741400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.097560E-02 |
| Normal-vs-N1 |
5.663900E-02 |
| N0-vs-N1 |
5.335600E-01 |
|
|
